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Purpose: Characterize the nutritional risk of critically ill patients with themodiﬁedNUTrition Risk in the Critically
ill (NUTRIC) score.
Materials: National, multicenter, prospective, observational study conducted in 15 polyvalent Portuguese inten-
sive care unit (ICU), during 6 months. Adult patients were eligible. Those transferred from another ICU or
readmitted, brain dead at admission, and with length of ICU stay (LOS) of 72 hours or less were excluded.
NUTRIC score was calculated at admission; scores ≥5 represent a high nutritional risk. Main outcome was mor-
tality from all causes at 28 days after admission to the ICU; LOS and days without mechanical ventilation (days
free of MV) were secondary outcomes.
Results: From 2061 admissions, 1143 patients were considered, mostly males (n = 744, 64.7%) with median
(P25-P75) age of 64 (51-75). Patients at high nutritional risk were 555 (48.6%). High NUTRIC score was associ-
atedwith longer LOS (P b .001), less days free of MV (P= .002) and higher 28-daymortality (P b .001). The area
under the curve of NUTRIC score ≥5 for predicting 28-day mortality was 0.658 (95% CI, 0.620-0.696). NUTRIC
score ≥5 had a positive predictive value 32.7% and a negative predictive value 88.8% for 28-day mortality.
Conclusions:Almost half of the patients in Portuguese ICUs are at high nutritional risk. NUTRIC scorewas strongly
associated with main clinical outcomes.
© 2016 Elsevier Inc. All rights reserved.1. Introduction
Malnutrition is common in hospitalized patients and highly preva-
lent in the population of critically ill patients all around the world
[1,2]. It is associatedwith increasedmorbidity,mortality andoccurrence
of nosocomial infections, prolonged hospitalization, worse functional
status at discharge from the Intensive Care Units (ICU) and increased
hospital costs [3,4].
In Portugal, data regarding the impact ofmalnutrition at hospital ad-
mission has demonstrated that the frequency of patients at nutritional
risk is very high, comprising 29% to 47%, depending on themethodology
used [5]. Data on Portuguese critically ill patients is still, to date, not
available.
Most of the scores and tools to assess nutritional risk were validated
in the hospital setting [6-12], and include a variety of criteria to identify, Hospital S. José, CHLC, Rua José
3.
des).nutritional risk, such as food/nutritional intake, physical examination,
severity of illness, anthropometric data and functional assessment.
Many of these criteria are difﬁcult to obtain in critically ill patients
since almost all of these patients require mechanical ventilation and se-
dation. Changes in weight can be inﬂuenced by ﬂuid status, given the
large volumes necessary tomaintain hemodynamic stability, and conse-
quentlymuscle and fat wasting evaluation becomemore difﬁcult. Many
traditional tools do not provide information regarding inﬂammatory
status which is crucial in an ICU population, since it's one of the factors
responsible for hypermetabolic status and hence, muscle wasting [13].
Based on the assumption that the nutritional risk is not the same for
all critically ill patients, Heyland et al developed and validated the NU-
Trition Risk in the Critically ill (NUTRIC score), the ﬁrst nutritional risk
assessment tool developed speciﬁcally for the ICU population that
could identify patients that requiremore aggressive nutritional support,
based on their nutritional risk [14,15]. The conceptual model links pa-
tient predictor markers of acute and chronic starvation, acute and
chronic inﬂammation and outcome. The severity of illness is derived
from the use of the variableswith traditional scores of severity of illness,
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[16] and baseline Sequential Organ Failure Assessment (SOFA) [17].
The variables in the NUTRIC score are easy to obtain in the critical
care setting, except Interleukin-6 (IL-6) level, which is not commonly
measured. As it has already been demonstrated, the performance of
the NUTRIC score varies only slightly when excluding IL-6 levels from
the score or when this is replaced by another available inﬂammatory
biomarker. Themodiﬁed NUTRIC score (without IL-6) has been recently
validated [18].
2. Objective
To characterize the nutritional risk of hospitalized patients in
Portuguese ICU using the modiﬁed NUTRIC score.
3. Materials
A prospective, observational, multicentric cohort study was con-
ducted in a convenient sample of tertiary polyvalent ICUs across
Portugal. Nationwide, around 4100 patients per year were expected to
be admitted in the ICUs. Polyvalent ICUs from public academic hospitals
were considered eligible to participate. From the 30 identiﬁed ICUs, 23
expressed the will to participate and 15 ICUs provided the complete
dataset for effective enrolment. All enrolled ICUs had allocated nutri-
tional staff. Patients consecutively admitted to the participant ICUs
were enrolled during a period of 6months, in 2014,with only admission
to the ICU being considered. Patients aged over 18 years were consid-
ered eligible for recruitment. Patients were excluded if diagnosed as
being brain dead at admission or if they had been transferred from an-
other ICU or readmitted into the ICU. Only patients with a length of
ICU stay (LOS) of more than 72 hours were considered for analysis.
The transcultural adaptation of the tool was previously done as an
independent part of the project. The process of cross-cultural adaptation
followed the multistep approach, according to the international guide-
lines [19]. The original English version of the NUTRIC score was inde-
pendently translated to Portuguese by two bilingual translators with
speciﬁc skills in English and Portuguese and proved experience in the
health sciences. A panel of experts (physicians, nurses and dietitians
working in ICU) evaluated the two translations of NUTRIC score, by an-
alyzing the phrasing of each item, and consensually obtaining the pro-
posed version. An ofﬁcial translator, registered in the Portuguese
Translators Society, proceeded to back-translate the proposed version
to English, the language of the original version. The back-translated ver-
sion was reviewed by the developers of the original tool to assess the
adequateness of the content (content validity). A pilot study was con-
ducted with 46 critically ill patients admitted in one of the ICU's from
the study, to assess the understanding and applicability of the translated
version of the modiﬁed NUTRIC Score. The cultural validation from
English to Portuguese language has succeeded in achieving idiomatic,
semantic, and conceptual equivalence between the original toll and
the Portuguese version. The ofﬁcial endorsement of the proposed
Portuguese version of the NUTRIC score was obtained.
The NUTRIC score, without IL-6 levels includes ﬁve variables: age,
APACHE II, SOFA, number of co-morbidities and days from hospital to
ICU admission. The score was calculated with data from the ﬁrst 24 h
after ICU admission. The NUTRC score ranges from zero to nine; a
score ≥5 indicates a high nutritional risk [14]. Main outcome was mor-
tality from all causes at 28 days after admission to the ICU; LOS and
days without invasive mechanical ventilation (days free of MV) were
secondary outcomes. Outcomes were collected until day 28, starting at
admission to the ICU. Data were recorded from the patient chart (elec-
tronic and/or paper) following the standardized data collection proce-
dures stated in the manual of procedures developed speciﬁcally for
the study. Local researchers received training to collect data. The study
was approved by the Ethics Committees for Health for every participant
Hospitals and was licensed in the Portuguese Data Protection Authority(no. 6635/2013). Asmandated by the sameAuthority, informed consent
was obtained from all patients included.
Prevalence rates are presented with 95% conﬁdence intervals (95%
CI). Proportions are compared with binomial test, χ2 test or Fisher
exact test (as adequate). The normality of the distribution of the
NUTRIC score was excluded. The association of the NUTRIC score with
the three main outcomes (LOS, days off MV and 28-day mortality)
was analyzedwithMann-WhitneyU test and Spearman correlation, ad-
justed to confounding factors when needed. Logistic regression analysis
was used to further characterize the association between the NUTRIC
score and the three main outcomes, using odds ratio (OR) with 95% CI
of the estimates; linear regression was performed but discarded due
to rejection of the normality of the residuals. The model discrimination
for predicting 28-day mortality was assessed by the area under the re-
ceiving operating characteristic curve (AUC) (interpretation: excellent
≥0.90, adequate 0.70-0.89, poor b0.70) and the generalized max-
rescaled R-squared statistic.
The following software packages were used for analysis: OpenEpi
(Dean AG, Sullivan KM, Soe MM. OpenEpi: Open Source Epidemiologic
Statistics for Public Health. www.OpenEpi.com, Version 2015/05/04,
accessed 2015/07/25), SISA (Uitenbroek, Daan G. SISA. 1997. http://
www.quantitativeskills.com/sisa.htm. (2015/07/25)), SPSS 22.0 (SPSS
for Windows, Rel. 22.0.1. 2013. SPSS Inc, Chicago, IL; EUA), Stata
(StataCorp. 2013. Stata Statistical Software: Release 13. College Station,
TX; StataCorp LP, USA) and VassarStats (Lowry R. VassarStats. http://
vassarstats.net/. Vassar College, Poughkeepsie, NY, USA, accessed
2015/07/25).4. Results
During the 6-month recruitment period, 2061 patients were eligible
for enrolment in the 15 participating ICUs and 1143 were included in
the analysis. Exclusion occurred in case the patient presented one of
the previously established criteria: 26were diagnosed brain dead at ad-
mission and 50 had been transferred from another ICU, informed con-
sent was not obtained from 149 patients and LOS in the ICU was less
than 72 hours in 670 patients; 23 patients were excluded from analysis
due to incomplete data collection for obtaining the NUTRIC score.
Patients that were excluded had similar age distribution than the re-
cruited sample, but a signiﬁcantly lower proportion were males (58.2%
vs 64.8%; P = .002) and had a signiﬁcantly lower baseline APACHE II
(median 17 vs 20; P= .009) and SOFA (median 5 vs 7; P b .001).
In the recruited sample, the median (P25-P75) age at admission was
64 (51-75) years. Males predominated (n = 740, 64.8%; P b .001). The
median (P25-P75) baseline APACHE II and SOFA were 20 (14-26) and 7
(5-10), respectively. Primary admission diagnoses were respiratory (n =
262, 23.0%), sepsis (n = 230, 20.2%) and trauma (n = 167, 14.6%); 2 or
more co-morbidities were present in 393 (34.4%) patients. Patients'
baseline characteristics are summarized in Table 1.
The median (P25-P75) of the days free of MV was 2 (1-4) days and
LOSwas 9 (5-15) days. At day 28, 243 of 1122 patients with known sta-
tus were deceased (21.7%; 95% CI, 19.35-24.16).
The median (P25-P75) of the NUTRIC score was 4 (3-6). There were
555 patients (48.6%; 95% CI, 45.67-51.45) at high nutritional risk
(NUTRIC score ≥5). Patients at high nutritional risk had higher median
(P25-P75) LOS 10 (5-16.5) days vs 8 (5-14) days (P b .001), less median
(P25-P75) days free of MV 2 (1-4) days vs 3 (1-4) days (P b .001), and
higher 28-day mortality 32.7% vs 11.2% (P b .001).
On logistic regression analysis, NUTRIC score ≥5 was associated with
longer LOS (≥9 days) (OR 1.72; 95% CI, 1.36-2.17; P b .001; n = 1126),
less days free of MV (≤2 days) (OR 1.46; 95% CI, 1.16-1.85; P= .002; n =
1124) and higher 28-day mortality (OR 3.84; 95% CI, 2.80-5.26; P b
.001; n = 1122). A NUTRIC score ≥5 predicted 28-day mortality with
AUC 0.658 (95% CI, 0.620-0.696) (Supplementary Fig. S1), with a posi-
tive predictive value of 32.7% (95% CI, 28.91-36.77) and a negative
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sensitivity was 73.25% (95% CI, 67.36-78.42) and speciﬁcity 58.4% (95%
CI, 55.07-61.58). The 28-day mortality prediction of the NUTRIC score,
at its full range, calculated by a logistic regression model, is compared
with the observed mortality rate in Fig. 1. The NUTRIC score as a full
scale (0-9) predicted 28-day mortality with AUC 0.718 (95% CI, 0.685-
0.752) (Fig. 2 and Table 2).
The comparison between the sample characteristics and the results
obtained in this studywith those of the original validation study arepre-
sented in Table 2.Fig. 1. The ability of the NUTRIC score to predict 28-day mortality. The graphic presents
both the mortality rates which were observed (circles) and predicted by the logistic
model (full line), the later with its 95% conﬁdence interval (broken line).5. Discussion
Most of the critically ill patients admitted to the ICU showmalnutri-
tion criteria [20]. Critical illness is typically associated with a catabolic
stress state, skeletalmuscleweakness, and as consequencewith compli-
cations such as increased infectiousmorbidity, multiple-organ dysfunc-
tion, difﬁcult weaning, prolonged hospitalization, and increased
mortality. The nutrition therapy is thought to help to attenuate themet-
abolic response to stress, prevent oxidative cellular injury andmodulate
immune responses. Delivering early nutrition support, by the enteral
route if possible, is a strategy that reduces disease severity, complica-
tions, decreases LOS in the ICU and improves patient outcomes [13]. It
is known that a poor nutritional status is associated with a worse out-
come, but the reversemay not be true since there are other factors asso-
ciated with illness or with the status of the patient that can negatively
inﬂuence the outcome regardless of nutritional status.
The NUTRIC score, ﬁrstly validated byHeyland et al, is the ﬁrst nutri-
tional risk assessment tool developed speciﬁcally for the ICU population
that can identify patients at risk formalnutrition. Later Rahman et al val-
idated the modiﬁed NUTRIC, which allows the exclusion of the IL-6
levels, if not available, to assess nutritional risk at admission.
This study was the ﬁrst to characterize the nutritional risk of hospi-
talized patients in Portuguese polyvalent ICUs; the study considered a
large sample that was representative of annual ICU admissions inTable 1
Clinical characteristics of the sample of recruitedpatients. Values aremedian (P25-P75) or n (%).
Patients
(n = 1143)




Baseline APACHE II score 20 (14-26)
Baseline SOFA score 7 (5-10)




Heart failure 143 (12.4)
Chronic pulmonary disease 138 (12.1)
Neoplasms 152 (13.3)
Chronic kidney disease 69 (6.0)
Brain stroke or transient ischemic event 64 (5.6)
Depression, anxiety or panic disorders 55 (4.8)
Hypertension 47 (4.1)
Chronic liver disease 48 (4.2)










Renal 12 (1.1)Portugal and it assessed prospectively the effectiveness of the modiﬁed
NUTRIC score. High nutritional riskwas present in half of the sample. As
described in the original study [14,18] in ourworkNUTRIC scorewas as-
sociatedwith the target clinical outcomes; it had low positive predictive
value (32.7%) and high negative predictive value (88.8%) to predict 28-
day mortality. In this study patients at high nutritional risk had higher
LOS, fewer days free of MV and increased 28-day mortality. The mean
NUTRIC score in our study (4.4) is slightly (but not signiﬁcantly)
lower than that of the original validation of the NUTRIC score (4.7)
[14] though clearly lower than that of the second validation of the
score (5.5) [18]. The participants in this Portuguese (national) sample
show signiﬁcant differences on the variables included in the NUTRIC
score when compared to the original validation group [14]. In the pres-
ent study, participants were signiﬁcantly older, had higher proportions
of lower APACHE II scores, higher SOFA scores and a signiﬁcantly lower
proportion of participants had two ormore co-morbidities. These differ-
ences are due to both the clinical variability of the patients treated in the
ICU and the large size of the recruited sample in the present study. De-
spite these differences, this study ﬁnds the same association already de-
scribed between NUTRIC score and main clinical outcomes, which
endorses the use of toll in clinical settings with different demographic
characteristics from the original validation group.
It wasmore frequent for patients to be admitted to hospital formore
than 1 day before ICU admission in this study, compared to the original
validation study which could possibly be interpreted as a marker of
compromised nutritional intake and worse nutritional status. The 28-
day mortality in this Portuguese national sample (21.7%) is similar to
that of the original validation of the NUTRIC score (23.1%) [14] but it is
lower than that observed in the second validation of the score (29%)
[18]. The AUC is signiﬁcantly higher in the original validation study
but in both studies it is classiﬁed as “adequate”. In spite of the clinical
and statistical differences found between this study and other studies
[14,18], the described performance of the NUTRIC score to predict 28-
day mortality is clinically similar across these studies and the values of
the AUC ﬁt into the category of “adequate”. However, this study was
not planned to reassess the validation of the instrument, rather to use
it to characterize a sample of patients from a national sample of polyva-
lent ICUs.
The main strengths of this study are the large size of this national
sample, the prospective evaluation of the patients using a standardized
protocol and the clinical heterogeneity provided by the number of par-
ticipant ICUs. The unblinded nature of the study may have affected the
clinicians’ intervention, but in the absence of a uniformized therapeutic
protocol and with such a large number of patients, admitted to many
ICUs all over the country, any inﬂuence of biased interventions is prob-
ably minimized. The absence of data of nutritional support (either
Fig. 2. Performance of the NUTRIC score as a full scale (0-9) to predict 28-day mortality in patients admitted to polyvalent intensive care units for at least 72 hours. AUC= 0.718 (95% CI,
0.685-0.752; n = 1122).
48 R. Mendes et al. / Journal of Critical Care 37 (2017) 45–49enteral or parenteral) during ICU stay, the convenience sample and the
potential heterogeneity of therapeutic approaches are other weak-
nesses. The use of this tool on a daily basis for critically ill patients
seems to have the advantage of raising the importance of nutritional
support, drawing attention to high-risk patients for malnutrition. Con-
sidering that patients with high nutritional risk are expected to have
more difﬁculty in achieving their nutritional needs, especially protein
needs, we believe protocols should be implemented to optimizeTable 2
Values of the NUTRIC score system in the original development sample, the second validation s
present effectiveness study.




Age b50 0 130 (21.7
50-75 1 345 (57.7
≥75 2 123 (20.6
APACHE II b15 0 111 (18.6
15 - b20 1 135 (22.6
20 - b28 2 226 (37.8
≥28 3 126 (21.1
SOFA b6 0 220 (36.8
6 - b10 1 247 (41.3
≥10 2 131 (21.9
Co-morbidities 0-1 0 160 (26.8
≥2 1 438 (73.2
Days from hospital to ICU admission b1 0 375 (62.7
≥1 1 223 (37.3
IL6 b400 0 489 (81.8
≥400 1 109 (18.2
Score range (IQR) 0-10 (3-6
Score mean (SD) 4.7 (2.2)
AUC 0.783
Gen R-Squared 0.169
Gen Max-rescaled R-Squared 0.256delivery of nutritional therapy such as earlier introduction of motility
agents higher threshold of tolerance to gastric residual volume, and a
volume based strategy for delivery of enteral feeding (as opposed to
an hourly based strategy). If the strategies mentioned fail to achieve
the nutritional needs, those patients should be selected for supplemen-
tary parenteral nutritional. More prospective studies investigating
witch nutritional interventions could positively modify the patients











) 199 (16.6) 255 (22.3)
) 710 (59.2) 574 (50.2) .003
) 290 (24.2) 314 (27.5)
) 48 (4.0) 292 (25.6)
) 157 (13.1) 257 (22.5)
) 508 (42.4) 374 (32.7) .007
) 486 (40.5) 219 (19.2)
) 157 (13.1) 376 (32.9)
) 624 (52.0) 436 (38.1) .007
) 418 (34.9) 331 (29.0)
) 392 (32.7) 750 (65.6)
) 807 (67.3) 393 (34.4) b.001
) 757 (63.1) 466 (40.6)
) 442 (36.9) 678 (59.4) b.001
) - -
) - -
) 0-9 (4-7) 0-9 (3-6)
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The modiﬁed NUTRIC score, the ﬁrst nutritional risk assessment tool
developed and validated speciﬁcally for critically ill patients, demon-
strated that in ICU Portuguese patients, despite presenting different
characteristics from the original validated sample, a good correlation
with main clinical outcomes.
The modiﬁed NUTRIC score can be used widely and systematically,
contributing to discriminate ICU patients at high nutritional risk. The
cross-cultural adaptation of NUTRIC score demonstrated translation re-
liability and is acceptable to be used in critically ill patients.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.jcrc.2016.08.001.
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